Latest News

The Department of Health – Abu Dhabi supported this groundbreaking investigation, which aligns with the emirate’s commitment to preventing diseases before they develop.

The approval specifically targets patients who have already undergone one prior trastuzumab-based treatment regimen.

BMS will pay up to USD850 million, structured as USD50 million in upfront and near-term payments combined with USD800 million in regulatory, development, and milestone-based payouts.

The newly developed syringe has been specifically engineered to work seamlessly with Ypsomed’s YpsoMate 5.5 autoinjector platform.

The acquisition adds two key products to BioStem’s portfolio: Neox and Clarix, both cryopreserved amniotic membrane allografts.

The device works by carefully opening the obstructed prostate, providing relief from lower urinary tract symptoms that significantly impact patients’ daily lives.

The Democratic Republic of the Congo bore the heaviest burden, accounting for 96% of reported cases and 97% of deaths.

Medical professionals will now conduct tests for liver function, kidney function, cardiac markers, and tumour markers directly at the facility.

This move introduces advanced tools like the da Vinci robotic surgical system, promising to elevate medical care across the region.

Pfizer will assume complete responsibility for developing and bringing to market any vaccine products that utilize Matrix-M technology.